Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer I Hare

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Drug Targeting|October 9, 2012
Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancerJennifer I Hare, Elaine H Moase, Theresa M Allen
Anti-Cancer Agents in Medicinal Chemistry|November 15, 2006
Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancerTheresa M Allen, Wilson W K Cheng, Jennifer I Hare, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 11, 2015
Tumour stromal morphology impacts nanomedicine cytotoxicity in patient-derived xenograftsJuan A Delgado San Martin, Jennifer I Hare, James W T Yates, et al.
Advanced Drug Delivery Reviews|May 4, 2016
Challenges and strategies in anti-cancer nanomedicine development: An industry perspectiveJennifer I Hare, Twan Lammers, Marianne B Ashford, et al.
Plos Computational Biology|October 31, 2015
Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical ApproachJuan A Delgado-SanMartin, Jennifer I Hare, Alessandro P S de Moura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 25, 2010
Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacyAnitha M Thomas, Anita I Kapanen, Jennifer I Hare, et al.
Plos One|April 30, 2013
Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracilJennifer I Hare, Robert W Neijzen, Malathi Anantha, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2017
Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimersRichard M England, Jennifer I Hare, Jennifer Barnes, et al.
Magnetic Resonance Imaging|November 21, 2017
Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?Ross A Little, Hervé Barjat, Jennifer I Hare, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|October 9, 2012
Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancerJennifer I Hare, Elaine H Moase, Theresa M Allen
Anti-Cancer Agents in Medicinal Chemistry|November 15, 2006
Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancerTheresa M Allen, Wilson W K Cheng, Jennifer I Hare, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 11, 2015
Tumour stromal morphology impacts nanomedicine cytotoxicity in patient-derived xenograftsJuan A Delgado San Martin, Jennifer I Hare, James W T Yates, et al.
Advanced Drug Delivery Reviews|May 4, 2016
Challenges and strategies in anti-cancer nanomedicine development: An industry perspectiveJennifer I Hare, Twan Lammers, Marianne B Ashford, et al.
Plos Computational Biology|October 31, 2015
Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical ApproachJuan A Delgado-SanMartin, Jennifer I Hare, Alessandro P S de Moura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 25, 2010
Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacyAnitha M Thomas, Anita I Kapanen, Jennifer I Hare, et al.
Plos One|April 30, 2013
Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracilJennifer I Hare, Robert W Neijzen, Malathi Anantha, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2017
Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimersRichard M England, Jennifer I Hare, Jennifer Barnes, et al.
Magnetic Resonance Imaging|November 21, 2017
Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?Ross A Little, Hervé Barjat, Jennifer I Hare, et al.
Pageof 1